Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

54.77
Delayed Data
As of Feb 12
 +1.33 / +2.49%
Today’s Change
49.00
Today|||52-Week Range
137.05
-51.18%
Year-to-Date
No recent news for Ultragenyx Pharmaceutical Inc.

Today’s Trading

Previous close53.44
Today’s open54.33
Day’s range51.05 - 55.18
Volume735,789
Average volume (3 months)539,571
Market cap$2.1B
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+84.87%
Earnings growth (this year)-61.73%
Earnings growth (next 5 years)+75.40%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book9.46

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...+0.16+0.52%
ACADACADIA Pharmaceutica...+0.71+4.05%
MDCOMedicines Co-0.09-0.31%
MYGNMyriad Genetics Inc+0.09+0.26%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 23, 2016
EPS forecast (this quarter)-$1.16
Annual revenue (last year)$0.00
Annual profit (last year)-$59.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Emil D. Kakkis
CFO, Senior VP &
Head-Investor Relations
Shalini Sharp
Corporate headquarters
Novato, California

Forecasts

Partner Offers